Nynex Therapeutics Overview

  • Founded
  • 2016
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Nynex Therapeutics General Information


Developer of novel therapeutic technology designed to develop drugs for the treatment of cancer. The company's novel therapeutic technology provides anti-cancer therapeutics that helps in regulation of protein, degradation of cancer pro-survival proteins, enabling patients to get cured from cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Primary Office
  • 20600 Chagrin Boulevard
  • Suite 210
  • Cleveland, OH 44122
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nynex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2018 00000 Completed Out of Business
1. Angel (individual) 15-Mar-2017 00000 00000 Completed Startup
To view Nynex Therapeutics’s complete valuation and funding history, request access »

Nynex Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Hollis Showalter Ph.D Co-Founder
Matthew Young Ph.D Co-Founder
Moshe Talpaz MD Co-Founder
Nicholas Donato Ph.D Co-Founder
To view Nynex Therapeutics’s complete executive team members history, request access »